Contracts › 75N93024C00069
75N93024C00069: Cutting Edge Technologies Will Be Used to Both Discover and Characterize Human B Cell Epitopes on Bacterial Surface Antigens Known to Be Involved in Immunity to B. Burgdoreri Infection.
Awarded to Health Research, Inc. by National Institutes of Health (NIH).
$5.9Mobligated
$9.9Mpotential value
15 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93024C00069 |
|---|---|
| Awardee | Health Research, Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NY |
| Offers received | 18 |
| Period of performance | 16 September 2024 to 15 September 2027 |
| Potential end | 15 September 2029 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record